Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftheria Hatzimichael

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Journal of Drug Delivery|March 28, 2013
Cancer epigenetics: new therapies and new challengesEleftheria Hatzimichael, Tim Crook
Haematologica|November 5, 2013
Metronomic chemotherapy beyond misconceptionsEleftheria Hatzimichael, Evangelos Briasoulis
International Journal of Hematology|March 11, 2016
Megaloblastic anemia presenting with skin hyperpigmentationEleftheria Hatzimichael, Evangelos Briasoulis
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2012
Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patientsGeorge Dranitsaris, Eleftheria Hatzimichael
Clinical Lymphoma, Myeloma & Leukemia|July 29, 2014
Delta-like homologue 1 and its role in the bone marrow niche and hematologic malignanciesLeonidas Benetatos, Eleftheria Hatzimichael
Stem Cells and Cloning : Advances and Applications|November 8, 2013
Hematopoietic stem cell transplantationEleftheria Hatzimichael, Mark Tuthill
Diseases (Basel, Switzerland)|June 23, 2022
Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid LeukemiaGeorgios Petros Barakos, Eleftheria Hatzimichael
Cellular and Molecular Life Sciences : CMLS|July 31, 2013
Polycomb group proteins and MYC: the cancer connectionLeonidas Benetatos, George Vartholomatos, Eleftheria Hatzimichael
Cellular and Molecular Life Sciences : CMLS|August 8, 2014
DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mistLeonidas Benetatos, George Vartholomatos, Eleftheria Hatzimichael
Molecular Biology Reports|April 11, 2025
Targeting the undruggable MYC in cancer: the rationale of using XPO1 inhibitorsLeonidas Benetatos, Eleftheria Hatzimichael, Eleni Kapsali
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Journal of Drug Delivery|March 28, 2013
Cancer epigenetics: new therapies and new challengesEleftheria Hatzimichael, Tim Crook
Haematologica|November 5, 2013
Metronomic chemotherapy beyond misconceptionsEleftheria Hatzimichael, Evangelos Briasoulis
International Journal of Hematology|March 11, 2016
Megaloblastic anemia presenting with skin hyperpigmentationEleftheria Hatzimichael, Evangelos Briasoulis
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2012
Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patientsGeorge Dranitsaris, Eleftheria Hatzimichael
Clinical Lymphoma, Myeloma & Leukemia|July 29, 2014
Delta-like homologue 1 and its role in the bone marrow niche and hematologic malignanciesLeonidas Benetatos, Eleftheria Hatzimichael
Stem Cells and Cloning : Advances and Applications|November 8, 2013
Hematopoietic stem cell transplantationEleftheria Hatzimichael, Mark Tuthill
Diseases (Basel, Switzerland)|June 23, 2022
Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid LeukemiaGeorgios Petros Barakos, Eleftheria Hatzimichael
Cellular and Molecular Life Sciences : CMLS|July 31, 2013
Polycomb group proteins and MYC: the cancer connectionLeonidas Benetatos, George Vartholomatos, Eleftheria Hatzimichael
Cellular and Molecular Life Sciences : CMLS|August 8, 2014
DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mistLeonidas Benetatos, George Vartholomatos, Eleftheria Hatzimichael
Molecular Biology Reports|April 11, 2025
Targeting the undruggable MYC in cancer: the rationale of using XPO1 inhibitorsLeonidas Benetatos, Eleftheria Hatzimichael, Eleni Kapsali
Pageof 12